{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:46:55Z","timestamp":1781059615218,"version":"3.54.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"DFG","award":["Walter-Benjamin-Fellowship 564169994"],"award-info":[{"award-number":["Walter-Benjamin-Fellowship 564169994"]}]},{"name":"NIH","award":["R37 AI179640"],"award-info":[{"award-number":["R37 AI179640"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"DOI":"10.1007\/s11904-026-00777-0","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:15:48Z","timestamp":1774080948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["T-Cell Profiles in HBV Functional Cure and People Living With HIV: Known Knowns, Known Unknowns, and Unknown Unknowns"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-6503","authenticated-orcid":false,"given":"Martin","family":"Feuerherd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9611-9476","authenticated-orcid":false,"given":"Jasmin","family":"Mischke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9792-4271","authenticated-orcid":false,"given":"Georg M.","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"key":"777_CR1","unstructured":"WHO. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016\u20132021: actions for impact. Geneva2021."},{"issue":"2","key":"777_CR2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/QAI.0b013e3182a60f7d","volume":"64","author":"RL Hamers","year":"2013","unstructured":"Hamers RL, Zaaijer HL, Wallis CL, Siwale M, Ive P, Botes ME, et al. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes. J Acquir Immune Defic Syndr. 2013;64(2):174\u201382.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"777_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1053\/j.gastro.2018.10.027","volume":"156","author":"YH Yeo","year":"2019","unstructured":"Yeo YH, Ho HJ, Yang HI, Tseng TC, Hosaka T, Trinh HN, et al. Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis. Gastroenterology. 2019;156(3):635\u201346. e9.","journal-title":"Gastroenterology"},{"issue":"6","key":"777_CR4","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/cid\/ciad654","volume":"78","author":"MJ Vinikoor","year":"2024","unstructured":"Vinikoor MJ, Hamusonde K, Muula G, Asombang M, Riebensahm C, Chitundu H, et al. Long-term Hepatitis B and Liver Outcomes Among Adults Taking Tenofovir-Containing Antiretroviral Therapy for HBV\/HIV Coinfection in Zambia. Clin Infect Dis. 2024;78(6):1583\u201390.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"777_CR5","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/jvh.12175","volume":"21","author":"R Strassl","year":"2014","unstructured":"Strassl R, Reiberger T, Honsig C, Payer BA, Mandorfer M, Grabmeier-Pfistershammer K, et al. Viral determinants predicting hepatitis B surface antigen (HBsAg) seroclearance in HIV-\/HBV-coinfected patients. J Viral Hepat. 2014;21(7):508\u201316.","journal-title":"J Viral Hepat"},{"issue":"4","key":"777_CR6","doi-asserted-by":"publisher","first-page":"e61297","DOI":"10.1371\/journal.pone.0061297","volume":"8","author":"GV Matthews","year":"2013","unstructured":"Matthews GV, Ali RJ, Avihingsanon A, Amin J, Hammond R, Bowden S, et al. Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals. PLoS ONE. 2013;8(4):e61297.","journal-title":"PLoS ONE"},{"issue":"3","key":"777_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw140","volume":"3","author":"M Anderson","year":"2016","unstructured":"Anderson M, Gaseitsiwe S, Moyo S, Thami KP, Mohammed T, Setlhare D, et al. Slow CD4(+) T-cell recovery in human immunodeficiency virus\/hepatitis B virus-coinfected patients initiating Truvada-based combination antiretroviral therapy in Botswana. Open Forum Infectious Diseases. 2016;3(3):ofw140.","journal-title":"Open Forum Infectious Diseases"},{"issue":"1","key":"777_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","volume":"22","author":"M Iannacone","year":"2022","unstructured":"Iannacone M, Guidotti LG. Immunobiology and pathogenesis of hepatitis B virus infection. Nat Rev Immunol. 2022;22(1):19\u201332.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"777_CR9","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","volume":"83","author":"European Association for the Study of the L","year":"2025","unstructured":"European Association for the Study of the L. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2025;83(2):502\u201383.","journal-title":"J Hepatol"},{"issue":"1","key":"777_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1055\/s-2003-37590","volume":"23","author":"G Fattovich","year":"2003","unstructured":"Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis. 2003;23(1):47\u201358.","journal-title":"Semin Liver Dis"},{"issue":"11","key":"777_CR11","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem D, Prince AM. Hepatitis B virus infection\u2013natural history and clinical consequences. N Engl J Med. 2004;350(11):1118\u201329.","journal-title":"N Engl J Med"},{"issue":"10","key":"777_CR12","doi-asserted-by":"publisher","first-page":"110107","DOI":"10.4254\/wjh.v17.i10.110107","volume":"17","author":"S Marrapu","year":"2025","unstructured":"Marrapu S, Soni JR, Kamal K, Kumar R. Hepatitis B functional cure: current and future perspective. World J Hepatol. 2025;17(10):110107.","journal-title":"World J Hepatol"},{"issue":"1","key":"777_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJM200107053450107","volume":"345","author":"GM Lauer","year":"2001","unstructured":"Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345(1):41\u201352.","journal-title":"N Engl J Med"},{"issue":"8","key":"777_CR14","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41590-021-00979-1","volume":"22","author":"KB Yates","year":"2021","unstructured":"Yates KB, Tonnerre P, Martin GE, Gerdemann U, Al Abosy R, Comstock DE, et al. Epigenetic scars of CD8(+) T cell exhaustion persist after cure of chronic infection in humans. Nat Immunol. 2021;22(8):1020\u20139.","journal-title":"Nat Immunol"},{"issue":"8","key":"777_CR15","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/s41590-021-00982-6","volume":"22","author":"P Tonnerre","year":"2021","unstructured":"Tonnerre P, Wolski D, Subudhi S, Aljabban J, Hoogeveen RC, Damasio M, et al. Differentiation of exhausted CD8(+) T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory. Nat Immunol. 2021;22(8):1030\u201341.","journal-title":"Nat Immunol"},{"issue":"3","key":"777_CR16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1053\/j.gastro.2004.06.015","volume":"127","author":"GM Lauer","year":"2004","unstructured":"Lauer GM, Barnes E, Lucas M, Timm J, Ouchi K, Kim AY, et al. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology. 2004;127(3):924\u201336.","journal-title":"Gastroenterology"},{"key":"777_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.715450","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wang X, Wu M, Ghildyal R, Yuan Z. Animal models for the study of hepatitis B virus pathobiology and immunity: past, present, and future. Front Microbiol. 2021;12:715450.","journal-title":"Front Microbiol"},{"key":"777_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2022.102186","volume":"76","author":"MA Boyd","year":"2022","unstructured":"Boyd MA, van Bockel D, Munier CML, Kelleher AD. Navigating the complexity of chronic HIV-1 associated immune dysregulation. Curr Opin Immunol. 2022;76:102186.","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"777_CR19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jhep.2022.02.020","volume":"77","author":"AJ Gehring","year":"2022","unstructured":"Gehring AJ, Mendez P, Richter K, Ertl H, Donaldson EF, Mishra P, et al. Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection. J Hepatol. 2022;77(2):525\u201338.","journal-title":"J Hepatol"},{"key":"777_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.05.041","author":"RC Hoogeveen","year":"2022","unstructured":"Hoogeveen RC, Dijkstra S, Bartsch LM, Drescher H, Aneja J, Robidoux MP, et al. Hepatitis B virus-specific CD4 T-cell responses differentiate functional cure from chronic surface antigen(+) infection. J Hepatol. 2022;77(5):1276\u20131286. https:\/\/doi.org\/10.1016\/j.jhep.2022.05.041.","journal-title":"J Hepatol"},{"issue":"5","key":"777_CR21","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/gutjnl-2018-316644","volume":"68","author":"RC Hoogeveen","year":"2019","unstructured":"Hoogeveen RC, Robidoux MP, Schwarz T, Heydmann L, Cheney JA, Kvistad D, et al. Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection. Gut. 2019;68(5):893\u2013904.","journal-title":"Gut"},{"key":"777_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316641","author":"A Schuch","year":"2019","unstructured":"Schuch A, Salimi Alizei E, Heim K, Wieland D, Kiraithe MM, Kemming J, et al. Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8\u2009+\u2009T cells in chronically HBV-infected patients with low viral load. Gut. 2019;68(5):905\u2013915. https:\/\/doi.org\/10.1136\/gutjnl-2018-316641.","journal-title":"Gut"},{"issue":"5","key":"777_CR23","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1128\/JVI.79.5.3038-3051.2005","volume":"79","author":"JJ Chang","year":"2005","unstructured":"Chang JJ, Wightman F, Bartholomeusz A, Ayres A, Kent SJ, Sasadeusz J, et al. Reduced hepatitis B virus (HBV)-specific CD4 + T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy. J Virol. 2005;79(5):3038\u201351.","journal-title":"J Virol"},{"issue":"9","key":"777_CR24","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/s41590-024-01928-4","volume":"25","author":"K Heim","year":"2024","unstructured":"Heim K, Sagar, Sogukpinar O, Llewellyn-Lacey S, Price DA, Emmerich F, et al. Attenuated effector T cells are linked to control of chronic HBV infection. Nat Immunol. 2024;25(9):1650\u201362.","journal-title":"Nat Immunol"},{"key":"777_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aau6905","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, Zhu YO, Becht E, Aw P, Chen J, Poidinger M, et al. Multifactorial heterogeneity of virus-specific T cells and association with the progression of human chronic hepatitis B infection. Sci Immunol. 2019;4(32):eaau6905. https:\/\/doi.org\/10.1126\/sciimmunol.aau6905.","journal-title":"Sci Immunol"},{"issue":"3","key":"777_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.bpg.2017.05.003","volume":"31","author":"LL Boeijen","year":"2017","unstructured":"Boeijen LL, Hoogeveen RC, Boonstra A, Lauer GM. Hepatitis B virus infection and the immune response: the big questions. Best Pract Res Clin Gastroenterol. 2017;31(3):265\u201372.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"777_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.20411\/pai.v2i1.201","volume":"2","author":"A Torres-Cornejo","year":"2017","unstructured":"Torres-Cornejo A, Lauer GM. Hurdles to the development of effective HBV immunotherapies and HCV vaccines. Pathog Immun. 2017;2(1):102\u201325.","journal-title":"Pathog Immun"},{"issue":"1","key":"777_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","volume":"77","author":"R Thimme","year":"2003","unstructured":"Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH, et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol. 2003;77(1):68\u201376.","journal-title":"J Virol"},{"issue":"10","key":"777_CR29","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.4049\/jimmunol.145.10.3442","volume":"145","author":"C Ferrari","year":"1990","unstructured":"Ferrari C, Penna A, Bertoletti A, Valli A, Antoni AD, Giuberti T, et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol. 1990;145(10):3442\u20139.","journal-title":"J Immunol"},{"issue":"7","key":"777_CR30","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1172\/JCI118592","volume":"97","author":"B Rehermann","year":"1996","unstructured":"Rehermann B, Lau D, Hoofnagle JH, Chisari FV. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest. 1996;97(7):1655\u201365.","journal-title":"J Clin Invest"},{"issue":"5","key":"777_CR31","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1136\/gutjnl-2018-316641","volume":"68","author":"A Schuch","year":"2019","unstructured":"Schuch A, Salimi Alizei E, Heim K, Wieland D, Kiraithe MM, Kemming J, et al. Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8 + T cells in chronically HBV-infected patients with low viral load. Gut. 2019;68(5):905\u201315.","journal-title":"Gut"},{"issue":"9","key":"777_CR32","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ni969","volume":"4","author":"RA Seder","year":"2003","unstructured":"Seder RA, Ahmed R. Similarities and differences in CD4 + and CD8 + effector and memory T cell generation. Nat Immunol. 2003;4(9):835\u201342.","journal-title":"Nat Immunol"},{"issue":"5","key":"777_CR33","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jhep.2022.05.041","volume":"77","author":"RC Hoogeveen","year":"2022","unstructured":"Hoogeveen RC, Dijkstra S, Bartsch LM, Drescher HK, Aneja J, Robidoux MP, et al. Hepatitis B virus-specific CD4 T cell responses differentiate functional cure from chronic surface antigen(+) infection. J Hepatol. 2022;77(5):1276\u201386.","journal-title":"J Hepatol"},{"issue":"10","key":"777_CR34","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/nbt.3662","volume":"34","author":"AK Bentzen","year":"2016","unstructured":"Bentzen AK, Marquard AM, Lyngaa R, Saini SK, Ramskov S, Donia M, et al. Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes. Nat Biotechnol. 2016;34(10):1037\u201345.","journal-title":"Nat Biotechnol"},{"issue":"7777","key":"777_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41586-019-1620-6","volume":"574","author":"AP Benechet","year":"2019","unstructured":"Benechet AP, De Simone G, Di Lucia P, Cilenti F, Barbiera G, Le Bert N, et al. Dynamics and genomic landscape of CD8(+) T cells undergoing hepatic priming. Nature. 2019;574(7777):200\u20135.","journal-title":"Nature"},{"issue":"8","key":"777_CR36","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1038\/s41590-025-02199-3","volume":"26","author":"V Venzin","year":"2025","unstructured":"Venzin V, Beccaria CG, Perucchini C, Delfino P, Bono EB, Giustini L, et al. CD4(+) T cells license Kupffer cells to reverse CD8(+) T cell dysfunction induced by hepatocellular priming. Nat Immunol. 2025;26(8):1352\u201366.","journal-title":"Nat Immunol"},{"key":"777_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.02.016","author":"FJ Jacobi","year":"2019","unstructured":"Jacobi FJ, Wild K, Smits M, Zoldan K, Csernalabics B, Flecken T, et al. OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection. J Hepatol. 2019;70(6):1103\u20131113. https:\/\/doi.org\/10.1016\/j.jhep.2019.02.016.","journal-title":"J Hepatol"},{"issue":"10","key":"777_CR38","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1172\/JCI121957","volume":"128","author":"L Salimzadeh","year":"2018","unstructured":"Salimzadeh L, Le Bert N, Dutertre CA, Gill US, Newell EW, Frey C, et al. PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection. J Clin Invest. 2018;128(10):4573\u201387.","journal-title":"J Clin Invest"},{"issue":"6","key":"777_CR39","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jhep.2014.07.005","volume":"61","author":"B Bengsch","year":"2014","unstructured":"Bengsch B, Martin B, Thimme R. Restoration of HBV-specific CD8\u2009+\u2009T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. J Hepatol. 2014;61(6):1212\u20139.","journal-title":"J Hepatol"},{"issue":"2","key":"777_CR40","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","volume":"138","author":"P Fisicaro","year":"2010","unstructured":"Fisicaro P, Valdatta C, Massari M, Loggi E, Biasini E, Sacchelli L, et al. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology. 2010;138(2):682\u201393.","journal-title":"Gastroenterology"},{"issue":"8","key":"777_CR41","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s41590-021-00975-5","volume":"22","author":"MS Abdel-Hakeem","year":"2021","unstructured":"Abdel-Hakeem MS, Manne S, Beltra JC, Stelekati E, Chen Z, Nzingha K, et al. Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation. Nat Immunol. 2021;22(8):1008\u201319.","journal-title":"Nat Immunol"},{"issue":"2","key":"777_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41590-020-00817-w","volume":"22","author":"N Hensel","year":"2021","unstructured":"Hensel N, Gu Z, Sagar, Wieland D, Jechow K, Kemming J, et al. Memory-like HCV-specific CD8(+) T cells retain a molecular scar after cure of chronic HCV infection. Nat Immunol. 2021;22(2):229\u201339.","journal-title":"Nat Immunol"},{"issue":"10088","key":"777_CR43","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","volume":"389","author":"AB El-Khoueiry","year":"2017","unstructured":"El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C, et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial. Lancet. 2017;389(10088):2492\u2013502.","journal-title":"Lancet"},{"issue":"5","key":"777_CR44","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.jhep.2019.06.028","volume":"71","author":"E Gane","year":"2019","unstructured":"Gane E, Verdon DJ, Brooks AE, Gaggar A, Nguyen AH, Subramanian GM, et al. Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study. J Hepatol. 2019;71(5):900\u20137.","journal-title":"J Hepatol"},{"issue":"15","key":"777_CR45","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1016\/j.cell.2024.05.038","volume":"187","author":"F Andreata","year":"2024","unstructured":"Andreata F, Laura C, Rava M, Krueger CC, Ficht X, Kawashima K, et al. Therapeutic potential of co-signaling receptor modulation in hepatitis B. Cell. 2024;187(15):4078\u2013e9421.","journal-title":"Cell"},{"issue":"1","key":"777_CR46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.20121172","volume":"210","author":"D Peppa","year":"2013","unstructured":"Peppa D, Gill US, Reynolds G, Easom NJ, Pallett LJ, Schurich A, et al. Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J Exp Med. 2013;210(1):99\u2013114.","journal-title":"J Exp Med"},{"issue":"1","key":"777_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12964-023-01455-z","volume":"22","author":"M Huang","year":"2024","unstructured":"Huang M, Yu X, Wang Q, Jiang Z, Li X, Chen W, et al. The immune checkpoint TIGIT\/CD155 promotes the exhaustion of CD8 + T cells in TNBC through glucose metabolic reprogramming mediated by PI3K\/AKT\/mTOR signaling. Cell Commun Signal. 2024;22(1):35.","journal-title":"Cell Commun Signal"},{"issue":"8022","key":"777_CR48","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41586-024-07630-7","volume":"631","author":"M Bosch","year":"2024","unstructured":"Bosch M, Kallin N, Donakonda S, Zhang JD, Wintersteller H, Hegenbarth S, et al. A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection. Nature. 2024;631(8022):867\u201375.","journal-title":"Nature"},{"issue":"3","key":"777_CR49","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/hep.32331","volume":"76","author":"S Pal","year":"2022","unstructured":"Pal S, Dey D, Chakraborty BC, Nandi M, Khatun M, Banerjee S, et al. Diverse facets of MDSC in different phases of chronic HBV infection: impact on HBV-specific T-cell response and homing. Hepatology. 2022;76(3):759\u201374.","journal-title":"Hepatology"},{"issue":"4","key":"777_CR50","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/imm.13738","volume":"171","author":"J He","year":"2024","unstructured":"He J, Miao R, Chen Y, Wang H, Liu M. The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma. Immunology. 2024;171(4):445\u201363.","journal-title":"Immunology"},{"issue":"10","key":"777_CR51","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/jvh.13559","volume":"28","author":"Y He","year":"2021","unstructured":"He Y, Cai W, Chen J, Hu F, Li F, Lin W, et al. Persistent chronic immune activation in HIV\/HBV-coinfected patients after antiretroviral therapy. J Viral Hepat. 2021;28(10):1355\u201361.","journal-title":"J Viral Hepat"},{"issue":"1","key":"777_CR52","first-page":"61","volume":"22","author":"HF Lohr","year":"1995","unstructured":"Lohr HF, Weber W, Schlaak J, Goergen B, Meyer zum Buschenfelde KH, Gerken G. Proliferative response of CD4 + T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants. Hepatology. 1995;22(1):61\u20138.","journal-title":"Hepatology"},{"issue":"7484","key":"777_CR53","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nature12940","volume":"505","author":"G Doitsh","year":"2014","unstructured":"Doitsh G, Galloway NL, Geng X, Yang Z, Monroe KM, Zepeda O, et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature. 2014;505(7484):509\u201314.","journal-title":"Nature"},{"issue":"7","key":"777_CR54","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1182\/blood-2008-05-159301","volume":"112","author":"JM Brenchley","year":"2008","unstructured":"Brenchley JM, Paiardini M, Knox KS, Asher AI, Cervasi B, Asher TE, et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood. 2008;112(7):2826\u201335.","journal-title":"Blood"},{"issue":"7","key":"777_CR55","doi-asserted-by":"publisher","first-page":"e1009732","DOI":"10.1371\/journal.ppat.1009732","volume":"17","author":"M Chakhtoura","year":"2021","unstructured":"Chakhtoura M, Fang M, Cubas R, O\u2019Connor MH, Nichols CN, Richardson B, et al. Germinal center T follicular helper (GC-Tfh) cell impairment in chronic HIV infection involves c-Maf signaling. PLoS Pathog. 2021;17(7):e1009732.","journal-title":"PLoS Pathog"},{"issue":"3","key":"777_CR56","doi-asserted-by":"publisher","first-page":"e0153224","DOI":"10.1128\/jvi.01532-24","volume":"99","author":"JL Mitchell","year":"2025","unstructured":"Mitchell JL, Buranapraditkun S, Gantner P, Takata H, Dietze K, N\u2019Guessan KF, et al. Activation of CXCR3(+) Tfh cells and B cells in lymph nodes during acute HIV-1 infection correlates with HIV-specific antibody development. J Virol. 2025;99(3):e0153224.","journal-title":"J Virol"},{"issue":"3","key":"777_CR57","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1084\/jem.20181589","volume":"216","author":"I Barnstorf","year":"2019","unstructured":"Barnstorf I, Borsa M, Baumann N, Pallmer K, Yermanos A, Joller N, et al. Chronic virus infection compromises memory bystander T cell function in an IL-6\/STAT1-dependent manner. J Exp Med. 2019;216(3):571\u201386.","journal-title":"J Exp Med"},{"issue":"12","key":"777_CR58","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1097\/QAD.0b013e3283618487","volume":"27","author":"RB Hasley","year":"2013","unstructured":"Hasley RB, Hong C, Li W, Friesen T, Nakamura Y, Kim GY, et al. HIV immune activation drives increased Eomes expression in memory CD8 T cells in association with transcriptional downregulation of CD127. AIDS. 2013;27(12):1867\u201377.","journal-title":"AIDS"},{"issue":"7","key":"777_CR59","doi-asserted-by":"publisher","first-page":"e1004251","DOI":"10.1371\/journal.ppat.1004251","volume":"10","author":"M Buggert","year":"2014","unstructured":"Buggert M, Tauriainen J, Yamamoto T, Frederiksen J, Ivarsson MA, Michaelsson J, et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8 + T cells in HIV infection. PLoS Pathog. 2014;10(7):e1004251.","journal-title":"PLoS Pathog"},{"key":"777_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12080901","author":"JA Bohorquez","year":"2024","unstructured":"Bohorquez JA, Jagannath C, Xu H, Wang X, Yi G. T cell responses during human immunodeficiency virus\/Mycobacterium tuberculosis coinfection. Vaccines (Basel). 2024;12(8):901. https:\/\/doi.org\/10.3390\/vaccines12080901.","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"777_CR61","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.it.2012.01.011","volume":"33","author":"C Geldmacher","year":"2012","unstructured":"Geldmacher C, Koup RA. Pathogen-specific T cell depletion and reactivation of opportunistic pathogens in HIV infection. Trends Immunol. 2012;33(5):207\u201314.","journal-title":"Trends Immunol"},{"key":"777_CR62","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01728-18","author":"P Amelio","year":"2019","unstructured":"Amelio P, Portevin D, Hella J, Reither K, Kamwela L, Lweno O, et al. HIV infection functionally impairs Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses. J Virol. 2019;93(5):e01728\u201318. https:\/\/doi.org\/10.1128\/JVI.01728-18.","journal-title":"J Virol"},{"issue":"6","key":"777_CR63","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1097\/QAD.0000000000002844","volume":"35","author":"O Falade-Nwulia","year":"2021","unstructured":"Falade-Nwulia O, Seaberg EC, Snider AE, Rinaldo CR, Wolinsky SM, Witt MD, et al. Outcomes of acute hepatitis B virus (HBV) in HIV infection with and without HBV-active antiretroviral therapy. AIDS. 2021;35(6):991\u20133.","journal-title":"AIDS"},{"issue":"15","key":"777_CR64","doi-asserted-by":"publisher","first-page":"7649","DOI":"10.1128\/JVI.00183-09","volume":"83","author":"JJ Chang","year":"2009","unstructured":"Chang JJ, Sirivichayakul S, Avihingsanon A, Thompson AJ, Revill P, Iser D, et al. Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection. J Virol. 2009;83(15):7649\u201358.","journal-title":"J Virol"},{"key":"777_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-232","volume":"10","author":"X Zhang","year":"2013","unstructured":"Zhang X, Xing H, Feng X, Zhang H, Wang Y, Yan H. Hepatitis B virus (HBV)-specific T-cell responses to recombinant HBV core protein in patients with normal liver function and co-infected with chronic HBV and human immunodeficiency virus 1 (HIV-1). Virol J. 2013;10:232.","journal-title":"Virol J"},{"issue":"17","key":"777_CR66","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1097\/QAD.0b013e328359b7ae","volume":"26","author":"G Ren","year":"2012","unstructured":"Ren G, Esser S, Jochum C, Schlaak JF, Gerken G, Schadendorf D, et al. Interleukin 21 augments the hepatitis B virus-specific CD8 + T-cell response in vitro in patients coinfected with HIV-1. AIDS. 2012;26(17):2145\u201353.","journal-title":"AIDS"},{"key":"777_CR67","doi-asserted-by":"publisher","unstructured":"Preechanukul A, Alrubayyi A, Sun B, Arbe-Barnes E, Kokici J, Gorou F et al. Stem-like CD8 + T cells preserve HBV-specific responses in HBV\/HIV co-infection. Gut. 2025. https:\/\/doi.org\/10.1136\/gutjnl-2025-335461","DOI":"10.1136\/gutjnl-2025-335461"},{"issue":"7","key":"777_CR68","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1086\/428502","volume":"191","author":"RM Lascar","year":"2005","unstructured":"Lascar RM, Lopes AR, Gilson RJ, Dunn C, Johnstone R, Copas A, et al. Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection. J Infect Dis. 2005;191(7):1169\u201379.","journal-title":"J Infect Dis"},{"issue":"12","key":"777_CR69","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1086\/379896","volume":"188","author":"RM Lascar","year":"2003","unstructured":"Lascar RM, Gilson RJ, Lopes AR, Bertoletti A, Maini MK. Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus\/HBV coinfection. J Infect Dis. 2003;188(12):1815\u20139.","journal-title":"J Infect Dis"},{"issue":"6","key":"777_CR70","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1128\/JVI.02124-09","volume":"84","author":"M Crane","year":"2010","unstructured":"Crane M, Sirivichayakul S, Chang JJ, Avihingsanon A, Ubolyam S, Buranapraditkun S, et al. No increase in hepatitis B virus (HBV)-specific CD8\u2009+\u2009T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy. J Virol. 2010;84(6):2657\u201365.","journal-title":"J Virol"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-026-00777-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-026-00777-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-026-00777-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T10:02:02Z","timestamp":1774087322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-026-00777-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1007\/s11904-026-00777-0","relation":{},"ISSN":["1548-3576"],"issn-type":[{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a review article and did not require human subjects or animal research performed by the authors. Thus, no ethical approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All authors have contributed to this work and agree to submit it for publication in its current form. No data or images are reproduced in this submission without proper permissions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}